Somatic Mitochondrial DNA Point Mutations Used as Biomarkers to Demonstrate Genomic Heterogeneity in Primary Prostate Cancer

Figure 2

Electropherograms from initial tumor scan analysis. Two samples representing the same focus, one of which demonstrating detected mtDNA mutations in prostate tumor 3. The heteroduplex area is enlarged to illustrate 5% mutant fraction versus sample scored as nonmutated.